Janus Henderson Group pointed out that the acquisition proposal put forward by Victory Capital Management is not feasible.

Solid Biosciences (SLDB) recently disclosed that the company plans to hold a follow-up meeting with the U.S. Food and Drug Administration (FDA) in the first half of 2026, aiming to obtain further guidance on the potential accelerated approval pathway for its gene therapy SGT-003.

In the past 24 hours, the MarketVectorTM Digital Assets 100 Small Cap Index fell by 2.61%, currently at 2633.29 points, remaining mostly stable around 2620 points during the period—experiencing a narrow range of fluctuations at a low level.

FDIC official Hill: The U.S. backstop does not apply to stablecoins

MSCI Nordic Countries Index fell by 0.4%, closing at 376.75 points